These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 18256175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Grazax--treatment for grass pollen hay fever].
    Svendsen UG.
    Ugeskr Laeger; 2008 Jan 14; 170(3):135-7. PubMed ID: 18208728
    [Abstract] [Full Text] [Related]

  • 7. An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever.
    Kay AB.
    Drugs Today (Barc); 2007 Dec 14; 43(12):841-8. PubMed ID: 18174969
    [Abstract] [Full Text] [Related]

  • 8. Grazax for hay fever--what's new?
    Drug Ther Bull; 2010 May 14; 48(5):54-6. PubMed ID: 20447981
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
    Nasser S, Vestenbaek U, Beriot-Mathiot A, Poulsen PB.
    Allergy; 2008 Dec 14; 63(12):1624-9. PubMed ID: 19032235
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe.
    Canonica GW, Poulsen PB, Vestenbaek U.
    Respir Med; 2007 Sep 14; 101(9):1885-94. PubMed ID: 17611095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR, de Carpentier J.
    J Laryngol Otol; 2009 Jun 14; 123(6):683-4. PubMed ID: 18501039
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oralair®: sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis.
    Hong J, Bielory L.
    Expert Rev Clin Immunol; 2011 Jul 14; 7(4):437-44. PubMed ID: 21790286
    [Abstract] [Full Text] [Related]

  • 16. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen.
    Rondón C, Blanca-López N, Aranda A, Herrera R, Rodriguez-Bada JL, Canto G, Mayorga C, Torres MJ, Campo P, Blanca M.
    J Allergy Clin Immunol; 2011 Apr 14; 127(4):1069-71. PubMed ID: 21277626
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose dependence of immunological response to sublingual immunotherapy.
    Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F.
    Allergy; 2005 Jul 14; 60(7):952-6. PubMed ID: 15932387
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.